Assessment of D-FRS on external cohort in San Raffaele, Milan, Italy AUC 0.49, discrimination and calibration poor. 👉 Shows nicely why external validation is so important! Would love to see DISPAIR-FRS further validated externally! link.springer.com/article/10.1... @stefanopartelli.bsky.social

New: Failure to rescue (FTR) in early versus later severe anastomotic leakage after colorectal surgery - Annals of Surgery 8562 resections -> 3.3% severe leak rate FTR higher after leak after emergency resection versus elective (29% vs 11%) #OpenAccess 👇🧵1/2

Time flies and @bjsurgery.bsky.social / @bjsopen.bsky.social editorial assistants rotate. Huge gratitude goes to our out-going editorial assistants Yung Lee, @hansl16.bsky.social and Laura Maggino - I’ve learned a great deal from you! 🙏 Terms end, but you will be part of BJS Family forever!

New Impact Factors are out! JAMA Surgery 14.9 BJS 8.8 Annals of Surgery 6.4 BJS Open 4.5 Dis Col Rectum 3.7 J Trauma 3.7 Ann Surg Oncol 3.5 JACS 3.4 EJSO 2.9 Surgery 2.7 Surg Endosc 2.7 Colorectal Dis 2.7 WJS 2.5 Hernia 2.4 HPB 2.4 JGIS 2.4 Langenbeck’s 1.8 Scand J Surg 1.8

🔥🆕PERFECT RCT Preoperatively started antibiotic treatment did not decrease the risk of appendiceal perforation when appendectomy was performed within 24h in adult patients with presumed uncomplicated acute appendicitis. #IDsky A new standard of care? jamanetwork.com/journals/jam...

New 🇫🇮🇳🇴RCT out @jama.com/Surgery🔥 Results from antibiotics layer of the PERFECT trial: Antibiotics or no while awaiting for appendectomy for presumed uncompl appendicitis 1797 patients Perforations: 8.3% vs 8.9% Surg site infections: 1.6% vs 3.2% (p=0.03) jamanetwork.com/journals/jam...

Join us for NordicHPB/NOLCA conference in Helsinki 18.-19. September 2025. Stellar speakers on HPB surgery, advanced endoscopy (ERCP/EUS), robotic surgery and oncology! 10 days left to secure your place for early bird price (before May 19)! See nordichpb.com for info!

Read also Invited Commentary by Sara Myers & Jennifer Davids in @jama.com/Surgery -> LASER Focus on Long-Term Outcomes for Diverticular Disease

MedPage Today @medpagetoday.bsky.social : Upfront Surgery for Diverticulitis Reduced Recurrence Without Affecting QOL — At 4 years, LASER reported similar QOL and complications for surgery and conservative treatment www.medpagetoday.com/gastroentero...

LASER trial 4-year results @jama.com/Surgery Sigmoid resection vs conservative treatment for recurrent diverticulitis: No difference in QOL or complications Recurrences 16% vs 92% BUT, 32% crossed conservative>surgery (pts w low QOL) Interpretation🤔: Surgery for pts w low QOL Open Access Link👇

And this is how it looks like in full action! #DavosCourse

All ready for Gastrointestinal Surgery DavosCourse! Record number of participants! Let’s go! 💪

From a really interesting thread posted by @scullingmonkey.bsky.social , this open access commentary is a real gem and should be of interest to all surgeons. There are discrepancies between what is being reported from the relevant RCT's versus what the data from a related registry actually reveal

Predicting risk for pancreatic fistula after left pancreatectomy: 2 risk scores were assessed in international cohort of 2284 patients from 🇫🇮🇬🇧🇸🇪🇫🇷🇳🇴🇨🇦🇩🇰 DISPAIR and D-FRS performed poorly 👉 We combined and validated new DISPAIR-FRS score with better performance Links 👇

How do patients in clinical trials compare to those we see in our clinical practice. We asked just that: Hot off the press in @bjsopen.bsky.social #vascular #medksy #bettertrials #evidencebasedmedicine Read here 👇 academic.oup.com/bjsopen/arti... 1/5

Duodecim-lehden 140v juhlasarja: Kommentoimme Panu Mentulan kanssa vuonna 1893 julkaistua kirjoitusta appendisiitista. Jo tuolloin tunnistettiin spontaanisti paraneva appendisiitti, jota silloin hoidettiin konservatiivisesti. Nyt ympyrä sulkeutuu, kun tähän ollaan palaamassa. Linkki 👇

Prospective multicenter study to develop and validate two risk scores to improve treatment of adhesive small bowel obstruction @bjsurgery.bsky.social STRISK: strangulation risk NOFA: non-op treatment failure risk Calc: www.tinyurl.com/strisk academic.oup.com/bjs/article/112/3/znaf025/8086860

🔹 Another fantastic #ESSO course on #PancreaticCancer successfully completed! 🔹 This time in a new location: Hamburg ! 🇩🇪✨ A big thank you to #ThiloHackert and #FelixNickel for hosting us, and to the amazing faculty @erangelova.bsky.social, @villesallinen.bsky.social, #AlainSauvanet and #SvenMieog

🔊 Editor Assistant Bursaries are now OPEN! 🔊 An exciting opportunity to join the BJS & BJS Open and gain hands-on editorial experience. Apply now or share with someone who’d be great for the role! ➡️ buff.ly/QJIDzFe @bjsurgery.bsky.social @bjsopen.bsky.social #SurgSky #MedSky

Happy to say our group got funded. Big thanks to @sigridjuselius.bsky.social for the continuous support for our research! www.sigridjuselius.fi/en/news/new-...

📢 Calling All Surgical Reviewers & Authors! Your insights matter! Help us improve the peer review process by taking our short survey. Together, we can shape the future of surgical research. 👉 Take the survey here: www.surveymonkey.com/r/YLY69HZ @drjuliomayol.bsky.social @bjsacademy.bsky.social

📝 Want to know how to write a clinical paper? We have a 4️⃣ part series dedicated to just that! 📽️ Watch part 2️⃣, taught by @villesallinen.bsky.social, Editor-in-Chief, of @bjsopen.bsky.social here ➡️ https://buff.ly/4b3QNzN #SurgSky #MedSky

Tuoreessa Duodecim-lehden podcastissä juttelemme Kari Hevossaaren kanssa mm anafylaksiasta, haimansiirroista ja rokotuksista! 👉 open.spotify.com/episode/2CEp...

Today my 6th PhD student Timo Tarvainen defended his thesis - Perioperative pharmacological mitigation of complications of pancreatic surgery + insights into Groove pancreatitis. We had a great honor to have Stefan Stättner from Austria as a fantastic opponent! Thread on findings 👇

LOVE YOUR LIVER - See Top 7 liver papers from BJS Journals 👇 🫵 Which one is your favourite?

Gastric partitioning versus gastrojejunostomy for gastric outlet obstruction due to unresectable gastric cancer: randomized clinical trial ➡️ doi.org/10.1093/bjso... #medsky #surgsky #gastrosky @bjsacademy.bsky.social @bjsurgery.bsky.social @drjuliomayol.bsky.social

COLLISION trial 🇳🇱 just out @TheLancetOncol 1st RCT: Ablation vs surgery for small (<3cm, <10 mets) colorectal liver mets ☑️Overall survival similar ☑️Slightly better local control per tumor in ablation group! ☑️Less adverse events in ablation group www.thelancet.com/journals/lan...

Such a great, funny, heart-breaking interview between John Monson & Neil Smart. For everybody who hasn’t watched it yet, this is a must-see. #surgsky @bjsurgery.bsky.social @drjuliomayol.bsky.social @sages.org @liangrhea.bsky.social @villesallinen.bsky.social www.youtube.com/watch?v=MyXJ...

JAMA Guide to Statistics and Methods: Factorial clinical trial designs allow for the simultaneous evaluation of multiple treatments and their interactions. ja.ma/4gTWOB8 #MedSky

Important decision: Finland Publication Forum will downgrade hundreds of Frontiers and MDPI journals. Among those are Frontiers in Surgery and Frontiers in Endocrinology. ://retractionwatch.com/2024/12/24/finland-publication-forum-will-downgrade-hundreds-of-frontiers-and-mdpi-journals/

My take on NICHE-2 trial 👇 - GastroDigest @ @gastroenterology.bsky.social authors.elsevier.com/a/1kK2d3mEmj...

Our MOBILE2 trial Top4 viewed paper @jama.com/surgery with >30k views! And total two papers from Finland🇫🇮 on Top10 list. Many more trials already running, quite a few in the pipeline to be started, several new ideas under marinade! read.alerts.jamanetwork.com/csb/Public/s...

Part 2 of 2️⃣0️⃣2️⃣4️⃣ HPB Wrapped with SSO! 🎊🎙️ with Drs Allison Martin & Ryan Ellis Top 🔟 studies 🌟 - in this episode: 5⃣NETTER-2 4⃣NEOLUPANET 3⃣TRANSMET 2⃣PANDORINA 1⃣NORPACT Any of them changing your practice in 2025? 🎧 tinyurl.com/yevzyfuw #HPBSky #SurgSky #MedSKy #OncSky

First hand #transplantation in Finland performed in Helsinki Univ Hospital @HUS_fi in Nov 2024! Patient doing well and about to be discharged. www.hus.fi/en/newsroom/... @esottransplant.bsky.social

PRICE-2 trial out @LancetGastroHep : Hypovolemic phlebotomy (7-10 mL/kg) versus usual care for liver resection w high risk of blood loss. Primary outcome: blood transfusion —> Phlebotomy 8% —> Usual care 16% Severe complication rate similar (17% vs 16%) www.thelancet.com/journals/lan...

The @bjsurgery.bsky.social and @bjsopen.bsky.social editors meeting Always inspired and intellectually stimulated by this group of surgeons, scientist and thinkers #HBPSky #SurgSky

What is the nationwide 🇳🇱 trend and outcome of robotic vs laparoscopic liver surgery? 🔑 Robot less conversion 🔑 Robot less blood loss 🔑 Robot short hospital stay journals.lww.com/aosopen/full... @eahpba.bsky.social @ihpba.bsky.social Rutger Jan Swijnenburg, Gabi Pilz da Cunha, Jeroen Hagendoorn

The mesopancreas: fact or fiction !? 🧐 Radiological morphology ☢️ could predict outcomes after PD for PDAC 🎯 Solid infiltration VS. fat stranding predicts poor prognosis 🫵 How do you appraoch this 🔑 area?! 🆓 access paper in @bjsopen.bsky.social academic.oup.com/bjsopen/arti...

To see surgical pictures, like the ones published in journals: go to the WEBSITE bsky.app, then “settings”, then “moderation” and allow adult content. You can then select what you want to see. This can’t be done in the app. #medsky #orthosky Please amplify. This is a huge problem on this site

Very honored to do the @BJSurgery lecture on the Emerging role of AI in Vascular Surgery. @BJSAcademy #VSASM2024 Brighton - 🇬🇧 Thanks to the Society of Great Britain and Ireland and @GarnhamAndy for this incredible meeting !

So are the going to be our new hashtags on BlueSky? #LiverSky #MedSky #PancSky #HPBSky #SurgerySky What else?? @augishealth.bsky.social @ihpba.bsky.social @eahpba.bsky.social @collegeofsurgeons.bsky.social @bjsacademy.bsky.social @sages.org

🎗️ This #PancreaticCancerAwareness Month, we’re spotlighting 7️⃣ important studies published this year in @bjsurgery.bsky.social & @bjsopen.bsky.social on #PancreaticCancer. ➡️ https://buff.ly/3ZgIX1q 💜 Over the coming days, we’ll be highlighting each of these studies. #ResearchMatters

Excellent work from the Dutch Pancreatitis Study Group! See our commentary on the long-term outcomes of the ESCAPE trial. What are your thoughts? Will this change how you treat chronic pancreatitis?

Today #JAMAsurg: long term outcomes #ESCAPE RCT: early #surgery remains superior to #endoscopy first in pts with wide-duct #chronic #pancreatitis ✅ Lower Izbicki pain scores ✅ Lower number of reinterventions ✅ Lower VAS pain scores ✅ Higher patient satisfaction ▶️ jamanetwork.com/journals/jam...

Thanks to HEPATOLOGY journal for this special issue on alcohol-associated liver disease & the chance to review this alarming global crisis 🚨🌎: >11M life-years lost annually, leading cause of liver Tx, and rising impact on young people 🙏 Amazing author team⭐️ journals.lww.com/hep/fulltext...

When interviewing candidates for a leadership role, I learn so much from two questions: 1. What have you built? 2. Who have you developed? Most who got that far have a lot to say on #1, but the best candidates pull away on #2.

Cytoreductive surgery + HIPEC for recurrent ovarian cancer improves overall survival! Multicenter RCT - 415 patients Median overall survival: HIPEC 54mo No HIPEC 46mo www.thelancet.com/journals/lan...

Welcome to @bjsopen.bsky.social under Blue Skies! Give them a follow for surgical updates with high-impact research. #HPBSky #SurgSky #MedSky

Here are more than a few that I have found so far #SurgSky go.bsky.app/JhPwuUd

Transplant for liver metastases? 🫢How?😳 Why?😬 Join the SSO and ASTS for virtual tumor board discussions with experts 📆 December 4th ⏰ 6PM CST Register: ow.ly/pMIR50U4HpP #HPBSky #MedSky #SurgSky #GISky